206 related articles for article (PubMed ID: 19040206)
1. Immunization with pseudotype baculovirus expressing envelope protein of Japanese encephalitis virus elicits protective immunity in mice.
Li Y; Ye J; Cao S; Xiao S; Zhao Q; Liu X; Jin M; Chen H
J Gene Med; 2009 Feb; 11(2):150-9. PubMed ID: 19040206
[TBL] [Abstract][Full Text] [Related]
2. Screening of protective antigens of Japanese encephalitis virus by DNA immunization: a comparative study with conventional viral vaccines.
Chen HW; Pan CH; Liau MY; Jou R; Tsai CJ; Wu HJ; Lin YL; Tao MH
J Virol; 1999 Dec; 73(12):10137-45. PubMed ID: 10559329
[TBL] [Abstract][Full Text] [Related]
3. Studies in the development of Japanese encephalitis vaccine: expression of virus envelope glycoprotein V3 (E) gene in yeast.
Fujita H; Sumiyoshi H; Mori C; Manabe S; Takagi M; Yoshida I; Morita K; Fuke I; Fukai K; Igarashi A
Bull World Health Organ; 1987; 65(3):303-8. PubMed ID: 2822272
[TBL] [Abstract][Full Text] [Related]
4. Protection of mice against Japanese encephalitis virus by passive administration with monoclonal antibodies.
Kimura-Kuroda J; Yasui K
J Immunol; 1988 Nov; 141(10):3606-10. PubMed ID: 2460542
[TBL] [Abstract][Full Text] [Related]
5. A single intramuscular injection of recombinant plasmid DNA induces protective immunity and prevents Japanese encephalitis in mice.
Chang GJ; Hunt AR; Davis B
J Virol; 2000 May; 74(9):4244-52. PubMed ID: 10756038
[TBL] [Abstract][Full Text] [Related]
6. Epitope(s) involving amino acids of the fusion loop of Japanese encephalitis virus envelope protein is(are) important to elicit protective immunity.
Fan Y-C; Chen J-M; Chen Y-Y; Ke Y-D; Chang G-JJ; Chiou S-S
J Virol; 2024 Apr; 98(4):e0177323. PubMed ID: 38530012
[TBL] [Abstract][Full Text] [Related]
7. Complete protection for mice conferred by a DNA vaccine based on the Japanese encephalitis virus P3 strain used to prepare the inactivated vaccine in China.
Zheng X; Yu X; Wang Y; Turtle L; Cui M; Wang R; Yin C
Virol J; 2020 Aug; 17(1):126. PubMed ID: 32831096
[TBL] [Abstract][Full Text] [Related]
8. A Japanese encephalitis virus peptide present on Johnson grass mosaic virus-like particles induces virus-neutralizing antibodies and protects mice against lethal challenge.
Saini M; Vrati S
J Virol; 2003 Mar; 77(6):3487-94. PubMed ID: 12610124
[TBL] [Abstract][Full Text] [Related]
9. Field experiments on live attenuated Japanese encephalitis virus vaccine for swine.
Ueba N; Kimura T; Nakajima S; Kurimura T; Kitaura T
Biken J; 1978 Sep; 21(3):95-103. PubMed ID: 219844
[TBL] [Abstract][Full Text] [Related]
10. DNA immunization with Japanese encephalitis virus nonstructural protein NS1 elicits protective immunity in mice.
Lin YL; Chen LK; Liao CL; Yeh CT; Ma SH; Chen JL; Huang YL; Chen SS; Chiang HY
J Virol; 1998 Jan; 72(1):191-200. PubMed ID: 9420215
[TBL] [Abstract][Full Text] [Related]
11. Chimeric yellow fever virus 17D-Japanese encephalitis virus vaccine: dose-response effectiveness and extended safety testing in rhesus monkeys.
Monath TP; Levenbook I; Soike K; Zhang ZX; Ratterree M; Draper K; Barrett AD; Nichols R; Weltzin R; Arroyo J; Guirakhoo F
J Virol; 2000 Feb; 74(4):1742-51. PubMed ID: 10644345
[TBL] [Abstract][Full Text] [Related]
12. A molecularly cloned, live-attenuated japanese encephalitis vaccine SA14-14-2 virus: a conserved single amino acid in the ij Hairpin of the Viral E glycoprotein determines neurovirulence in mice.
Yun SI; Song BH; Kim JK; Yun GN; Lee EY; Li L; Kuhn RJ; Rossmann MG; Morrey JD; Lee YM
PLoS Pathog; 2014 Jul; 10(7):e1004290. PubMed ID: 25077483
[TBL] [Abstract][Full Text] [Related]
13. Two-way cross-protection between West Nile and Japanese encephalitis viruses in bonnet macaques.
Goverdhan MK; Kulkarni AB; Gupta AK; Tupe CD; Rodrigues JJ
Acta Virol; 1992 May; 36(3):277-83. PubMed ID: 1360756
[TBL] [Abstract][Full Text] [Related]
14. Development of the second generation Japanese encephalitis (JE) vaccine.
Igarashi A
Southeast Asian J Trop Med Public Health; 1988 Sep; 19(3):493-500. PubMed ID: 3217827
[TBL] [Abstract][Full Text] [Related]
15. [Effect of cytoxan on immune response of Japanese encephalitis virus killed and live vaccines].
Fang QA; Chen BQ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1989 Oct; 11(5):317-21. PubMed ID: 2561510
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of genotype-matched vaccine against re-emerging genotype V Japanese encephalitis virus.
Kim JD; Lee AR; Moon DH; Chung YU; Hong SY; Cho HJ; Kang TH; Jang YH; Sohn MH; Seong BL; Seo SU
Emerg Microbes Infect; 2024 Dec; 13(1):2343910. PubMed ID: 38618740
[TBL] [Abstract][Full Text] [Related]
17. Immune response to live-attenuated Japanese encephalitis vaccine (JE-CV) neutralizes Japanese encephalitis virus isolates from south-east Asia and India.
Bonaparte M; Dweik B; Feroldi E; Meric C; Bouckenooghe A; Hildreth S; Hu B; Yoksan S; Boaz M
BMC Infect Dis; 2014 Mar; 14():156. PubMed ID: 24656175
[TBL] [Abstract][Full Text] [Related]
18. Immunogenicity of peptides cleaved by cyanogen bromide from Japanese encephalitis virus envelope glycoprotein E.
Srivastava AK; Morita K; Igarashi A
Acta Virol; 1990 May; 34(3):228-38. PubMed ID: 1980396
[TBL] [Abstract][Full Text] [Related]
19. Comparison of protective immunity elicited by recombinant vaccinia viruses that synthesize E or NS1 of Japanese encephalitis virus.
Konishi E; Pincus S; Fonseca BA; Shope RE; Paoletti E; Mason PW
Virology; 1991 Nov; 185(1):401-10. PubMed ID: 1833876
[TBL] [Abstract][Full Text] [Related]
20. Analysis of Japanese encephalitis (JE) virus genome and implications for recombinant JE vaccine.
Yasui K; Miyamoto M; Kimura-Kuroda J; Yasuda A; Matsuura Y; Sato T; Kojima A; Kubonoya H
Southeast Asian J Trop Med Public Health; 1990 Dec; 21(4):663-9. PubMed ID: 1711716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
